Investigation of the effect of selenium and exercise on the elderly

The effect of eight weeks of selenium supplementation and Concurrent training on SOD, CAT, CRP, GPX, GR and lipid profile in elderly men

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180912041018N3

Enrollment

Registered

2023-11-20

Start date

2024-01-10

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging. Factors influencing health status and contact with health services, Routine general health check-up of defined subpopulation,

Interventions

Intervention 1: Intervention group 1: Concurrent training, 3 sessions per week, 60 minutes in the morning, strength and endurance training protocol will be performed on every other day and on even day

Eligibility

Sex/Gender

Male

Age

65 Years to 75 Years

Inclusion criteria

Inclusion criteria: The age range of the subjects should be between 65 and 75. Subjects must be able to perform daily activities and physical activity.

Exclusion criteria

Exclusion criteria: Use of antioxidant supplements up to 6 months before conducting the research Having chronic diseases, such as cardiovascular diseases, diabetes, acute joint disease, osteoporosis, bone fractures

Design outcomes

Primary

Measure	Time frame
Glutathione peroxidase. Timepoint: Measurement of glutathione peroxidase at the beginning of the study (before the start of the intervention) and 48 hours after the last training session. Method of measurement: By ELISA method and using ELISA kit.;Glutathione reductase. Timepoint: Measurement of Glutathione reductase at the beginning of the study (before the start of the intervention) and 48 hours after the last training session. Method of measurement: by ELISA method and using ELISA kit.;C Reactive Protein. Timepoint: Measurement of C-reactive protein at the beginning of the study (before the start of the intervention) and 48 hours after the last training session and in the fasting state. Method of measurement: By ELISA method and using ELISA kit.;Superoxide Dismutase. Timepoint: At the beginning of the study (before the start of the intervention) and 48 hours after the last training session and in the fasting state. Method of measurement: By ELISA method and using ELISA kit.;Catalase. Timepoint: At the beginning of the study (before the start of the intervention) and 48 hours after the last training session and in the fasting state. Method of measurement: By ELISA method and using ELISA kit.	—

Measure

Time frame

Glutathione peroxidase. Timepoint: Measurement of glutathione peroxidase at the beginning of the study (before the start of the intervention) and 48 hours after the last training session. Method of measurement: By ELISA method and using ELISA kit.;Glutathione reductase. Timepoint: Measurement of Glutathione reductase at the beginning of the study (before the start of the intervention) and 48 hours after the last training session. Method of measurement: by ELISA method and using ELISA kit.;C Reactive Protein. Timepoint: Measurement of C-reactive protein at the beginning of the study (before the start of the intervention) and 48 hours after the last training session and in the fasting state. Method of measurement: By ELISA method and using ELISA kit.;Superoxide Dismutase. Timepoint: At the beginning of the study (before the start of the intervention) and 48 hours after the last training session and in the fasting state. Method of measurement: By ELISA method and using ELISA kit.;Catalase. Timepoint: At the beginning of the study (before the start of the intervention) and 48 hours after the last training session and in the fasting state. Method of measurement: By ELISA method and using ELISA kit.

—

Secondary

Measure	Time frame
Low-density lipoproteins. Timepoint: At the beginning of the study (before the start of the intervention) and 48 hours after the last training session and fasting state. Method of measurement: ELISA method and use of ELISA kit.;Very low density lipoprotein. Timepoint: At the beginning of the study (before the start of the intervention) and 48 hours after the last training session and fasting state. Method of measurement: ELISA method and use of ELISA kit.;Cholesterol. Timepoint: At the beginning of the study (before the start of the intervention) and 48 hours after the last training session and fasting state. Method of measurement: ELISA method and use of ELISA kit.;Triglyceride. Timepoint: At the beginning of the study (before the start of the intervention) and 48 hours after the last training session and fasting state. Method of measurement: ELISA method and use of ELISA kit.	—

Measure

Time frame

Low-density lipoproteins. Timepoint: At the beginning of the study (before the start of the intervention) and 48 hours after the last training session and fasting state. Method of measurement: ELISA method and use of ELISA kit.;Very low density lipoprotein. Timepoint: At the beginning of the study (before the start of the intervention) and 48 hours after the last training session and fasting state. Method of measurement: ELISA method and use of ELISA kit.;Cholesterol. Timepoint: At the beginning of the study (before the start of the intervention) and 48 hours after the last training session and fasting state. Method of measurement: ELISA method and use of ELISA kit.;Triglyceride. Timepoint: At the beginning of the study (before the start of the intervention) and 48 hours after the last training session and fasting state. Method of measurement: ELISA method and use of ELISA kit.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRouhollah Haghshenas

Semnan University

rhm@semnan.ac.ir0098 23 3342194

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026